Umbilical Cord Blood

Umbilical cord blood is the blood remaining in the placenta and umbilical cord after birth, providing a source of blood-forming stem and progenitor cells for biological and medical research. These hematopoietic cells can self-renew and differentiate into lineages that produce red blood cells, immune cells, and platelets; clinicians collect the blood from the cord, test it, and preserve it through cryopreservation. Cord blood transplantation can reconstitute bone marrow and treat selected blood and immune disorders, while laboratory studies use cord blood cells to investigate development, immunity, tissue regeneration, and cell-based therapies. Its limited cell dose and immune compatibility remain important considerations.

Umbilical Cord Blood - Related Videos

Research

JoVE Journal - Immunology and Infection
Free Sample

Isolation of Precursor B-cell Subsets from Umbilical Cord Blood

0 Views •

Cited by 2 •

2013

Here we describe a protocol for isolating subsets of precursor B-cells from umbilical cord blood. A sufficient quantity and quality of nucleic acids may be extracted from the cells and used in subsequent assays utilizing DNA or RNA.

Research

JoVE Journal - Developmental Biology

Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood

0 Views •

Cited by 16 •

2017

The goal of this protocol is to isolate endothelial progenitor cells from umbilical cord blood. Some of the applications include using these cells as a biomarker for identifying patients with cardiovascular risk, treating ischemic diseases, and creating tissue-engineered vascular and heart valve constructs.

Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood

0 Views •

Cited by 46 •

2012

Endothelial colony forming cells (ECFCs) are circulating endothelial cells with robust clonal proliferative potential that display intrinsic in vivo vessel forming ability. Phenotypic and functional characterization of outgrowth endothelial cells derived from CB are important to identify and isolate bona fide ECFCs for potential clinical application in repairing damaged tissues.

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

0 Views •

Cited by 53 •

2013

T cells expressing a CD19-specific chimeric antigen receptor (CAR) are infused as investigational treatment of B-cell malignancies in our first-in-human gene therapy trials. We describe genetic modification of T cells using the Sleeping Beauty (SB) system to introduce CD19-specific CAR and selective propagation on designer CD19+ artificial antigen presenting cells.

Isolation and Characterization of Mesenchymal Stromal Cells from Human Umbilical Cord and Fetal Placenta

0 Views •

Cited by 171 •

2017

Here, we present a protocol for the dissection of human umbilical cord (UC) and fetal placenta sample into cord lining (CL), Wharton's jelly (WJ), cord-placenta junction (CPJ), and fetal placenta (FP) for the isolation and characterization of mesenchymal stromal cells (MSCs) using the explant culture technique.

View All Results

FAQs

Related Topics